Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05739747
Status:
RECRUITING
Last Update Posted:
2023-07-25
First Post:
2023-02-05
Brief Title:
Validation of the Gendolcat Score for the Prognosis of Chronic Postoperative Pain in Cesarean Section
Sponsor:
Consorci Sanitari de Terrassa
Organization:
Consorci Sanitari de Terrassa
Study Overview
Official Title:
Validation of the Gendolcat Score for the Prognosis of Chronic Postoperative Pain in Cesarean Section
Status:
RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chronic post-surgical pain is a problem that has historically been underestimated Over the last few years there has been a search for strategies to both predict and prevent its occurrence in patients undergoing surgery The Gendolcat index is the only predictive model that uses only objective pre-surgical variables to assess the risk of suffering chronic post-surgical pain However it is only validated for the following surgeries thoracotomy hysterectomy and open inguinal hernia Our aim is to test whether the Gendolcat model is also valid for cesarean section
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None